The strong trader consensus reflected in the 96.2% implied probability against a new coronavirus pandemic in 2026 arises from WHO's August 2026 moderate global risk assessment for SARS-CoV-2, which notes sustained but low-level circulation with a 1.7% test positivity rate and no novel variants under monitoring showing elevated public health risk. Confirmed case increases remain modest year-to-date, consistent with endemic patterns rather than exponential growth required for a pandemic declaration, while historical data on coronavirus spillovers indicate such events demand specific combinations of high transmissibility and immune evasion not currently observed. Routine genomic surveillance by WHO and CDC continues to track evolution, including in animal reservoirs, though realistic shifts could still occur from an undetected mutation enabling efficient human-to-human spread or a new zoonotic event before year-end.